Year-over-year earnings per share growth for the last twelve months: Lyell Immunopharma (LYEL)

lyell.com (LYEL) - corporate logo

Lyell Immunopharma (LYEL) is recruiting leading bioinformaticians to advance its T-cell developments, creating a closed technological ecosystem to align medical centers with its standards. However, a lack of profitability and reliance on investor capital render revenues unpredictable. Quarterly net income per share growth exhibits volatility, with the current level of the metric standing at 12.30.

Lyell (LYEL) Year-over-year net earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for lyell.com (LYEL)

- share price and expert price forecast:
Comprehensive company analysis:Lyell, LYEL
Manufactured product of Lyell Immunopharma

Developing therapies for solid tumors requires colossal R&D investments and scientist compensation. This indicator compares net profit dynamics with the growth rate of operating expenses for Lyell Immunopharma (LYEL). It measures the business's ability to generate value per share faster than internal costs rise. Analyzing the quarterly shift in earnings per share reveals margin resilience to inflation. This chart allows an investor to determine the risk of income compression.

Competitors of Lyell Immunopharma

IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months januxrx.com|Year-over-year net earnings per share growth for the last 12 months arcusbio.com (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc (ZYME)|Year-over-year net earnings per share growth for the last 12 months Tango Pharma TNGX|Iovance Biotherapeutics Inc - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics Biotechnologies IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|CMPX (compasstherapeutics.com) - Year-over-year earnings per share growth for the last 12 months|Replimune Inc. (REPL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Innate Pharma, S.A. (IPHA)|Year-over-year net earnings per share growth for the last 12 months PYXS|CGEN - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months IOBT (IO Biotech Corp)|Year-over-year earnings per share growth rate for the last twelve months STRO|Quarterly EPS earnings growth INKT (MiNK Therapeutics)|Year-over-year earnings per one share growth for the last 12 months HOWL|Immix - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ALX Oncology Holdings Inc.|CUE: Quarterly EPS earnings growth|PDS Biotech - Year-over-year earnings per one share growth for the last 12 months|SONN (Sonnet BioTherapeutics Holdings Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth MAIA Biotech|Year-over-year earnings per share growth for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Year-over-year net earnings per share trend for the last twelve months|NextCure Inc - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics, Inc. (LPTX) - Earnings per share growth in annualized terms for the last twelve months|Intensity Therapeutics Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months senseibio.com SNSE|TOVX: Quarterly EPS earnings growth|Gritstone bio Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KA|Year-over-year earnings per share growth for the last 12 months NEXI (NexImmune, Inc.)|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics Corporation (TSBX)|Year-over-year net earnings per share growth for the last 12 months Vaccinex VCNX|Year-over-year earnings per share growth for the last twelve months harpoontx.com HARP